Cite
HARVARD Citation
Khoo, S. et al. (2023). Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet infectious diseases. 23 (2), pp. 183-195. [Online].